Financhill
Buy
52

TRI Quote, Financials, Valuation and Earnings

Last price:
$159.26
Seasonality move :
5.94%
Day range:
$158.57 - $160.27
52-week range:
$148.16 - $176.03
Dividend yield:
1.36%
P/E ratio:
31.35x
P/S ratio:
10.06x
P/B ratio:
6.03x
Volume:
190.6K
Avg. volume:
253.4K
1-year change:
7.69%
Market cap:
$71.6B
Revenue:
$6.8B
EPS (TTM):
$5.08

Analysts' Opinion

  • Consensus Rating
    Thomson Reuters has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 10 Hold ratings, and 2 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $166.36, Thomson Reuters has an estimated upside of 4.46% from its current price of $159.25.
  • Price Target Downside
    According to analysts, the lowest downside price target is $140.00 representing 100% downside risk from its current price of $159.25.

Fair Value

  • According to the consensus of 13 analysts, Thomson Reuters has 4.46% upside to fair value with a price target of $166.36 per share.

TRI vs. S&P 500

  • Over the past 5 trading days, Thomson Reuters has underperformed the S&P 500 by -0.22% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Thomson Reuters does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Thomson Reuters has grown year-over-year revenues for 17 quarters straight. In the most recent quarter Thomson Reuters reported revenues of $1.7B.

Earnings Growth

  • Thomson Reuters earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Thomson Reuters reported earnings per share of $0.67.
Enterprise value:
72.9B
EV / Invested capital:
--
Price / LTM sales:
10.06x
EV / EBIT:
38.74x
EV / Revenue:
10.18x
PEG ratio (5yr expected):
8.64x
EV / Free cash flow:
36.09x
Price / Operating cash flow:
35.67x
Enterprise value / EBITDA:
27.15x
Gross Profit (TTM):
--
Return On Assets:
12.28%
Net Income Margin (TTM):
32.12%
Return On Equity:
20.26%
Return On Invested Capital:
15.5%
Operating Margin:
24.07%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $6.6B $6.7B $7.2B $1.6B $1.7B
Gross Profit -- -- -- $1.3B $1.4B
Operating Income $1.4B $2.4B $1.6B $435M $415M
EBITDA $3B $2.7B $2.7B $772M $611M
Diluted EPS $1.98 $4.90 $5.08 $0.80 $0.67
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $3.2B $3B $2.3B $4.1B $3.4B
Total Assets $17B $23.1B $21.2B $19.3B $18.4B
Current Liabilities $2.1B $3.1B $3.4B $3.8B $3.6B
Total Liabilities $7.5B $8.9B $8.9B $8.2B $6.6B
Total Equity $9.6B $14.2B $12.3B $11.2B $11.9B
Total Debt $3.7B $3.8B $4.1B $4.4B $2.9B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $1.6B $2.3B $2.6B $674M $756M
Cash From Investing -$825M $3.8B $526M $435M -$218M
Cash From Financing -$1.9B -$4.1B -$3.9B -$1.4B -$492M
Free Cash Flow $1.1B $1.8B $2B $529M $607M
TRI
Sector
Market Cap
$71.6B
$726.7M
Price % of 52-Week High
90.47%
78.76%
Dividend Yield
1.36%
0%
Shareholder Yield
3.24%
2.32%
1-Year Price Total Return
7.69%
-0.14%
Beta (5-Year)
0.727
0.914
Dividend yield:
1.36%
Annualized payout:
$6.67
Payout ratio:
40.33%
Growth streak:
4 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $157.48
200-day SMA
Sell
Level $164.84
Bollinger Bands (100)
Sell
Level 161.88 - 170.42
Chaikin Money Flow
Buy
Level 101.1M
20-day SMA
Sell
Level $160.32
Relative Strength Index (RSI14)
Sell
Level 44.40
ADX Line
Sell
Level 49.05
Williams %R
Neutral
Level -32.1809
50-day SMA
Sell
Level $163.62
MACD (12, 26)
Sell
Level -2.06
25-day Aroon Oscillator
Sell
Level -80
On Balance Volume
Neutral
Level 160.3M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (6.6108)
Buy
CA Score (Annual)
Level (0.4758)
Buy
Beneish M-Score (Annual)
Level (-2.2399)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-2.1967)
Buy
Piotroski F Score (Annual)
Level (7)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Thomson Reuters is the result of the $17.6 billion megamerger of Canada’s Thomson and the United Kingdom’s Reuters Group in 2008. In 2021, Thomson Reuters completed the sale of Refinitiv to LSE Group. Thomson Reuters' three largest segments are its legal professionals, Tax and accounting, and corporates segments. Legal professionals is about 42% of the firm's revenue and 47% of the firm's adjusted EBITDA. Tax and accounting makes up about 20%-25% of the firm's revenue and EBITDA. Corporates, which consists of legal professionals and tax and accounting products sold to corporations, also makes up about 20%-25% of the firm's revenue and EBITDA. Thomson Reuters' smaller segments include its Reuters news business and global print business.

Stock Forecast FAQ

In the current month, TRI has received 1 Buy ratings 10 Hold ratings, and 2 Sell ratings. The TRI average analyst price target in the past 3 months is $166.36.

  • Where Will Thomson Reuters Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Thomson Reuters share price will rise to $166.36 per share over the next 12 months.

  • What Do Analysts Say About Thomson Reuters?

    Analysts are divided on their view about Thomson Reuters share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Thomson Reuters is a Buy and believe this share price will drop from its current level to $200.00.

  • What Is Thomson Reuters's Price Target?

    The price target for Thomson Reuters over the next 1-year time period is forecast to be $166.36 according to 13 Wall Street analysts, 1 of them rates the stock a Buy, 2 rate the stock a Sell, and 10 analysts rate the stock a Hold.

  • Is TRI A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Thomson Reuters is a Hold. 10 of 13 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of TRI?

    You can purchase shares of Thomson Reuters via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Thomson Reuters shares.

  • What Is The Thomson Reuters Share Price Today?

    Thomson Reuters was last trading at $159.26 per share. This represents the most recent stock quote for Thomson Reuters. Yesterday, Thomson Reuters closed at $159.25 per share.

  • How To Buy Thomson Reuters Stock Online?

    In order to purchase Thomson Reuters stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is AT&T Stock Dropping?
Why Is AT&T Stock Dropping?

The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…

Is American Express Stock Going Lower?
Is American Express Stock Going Lower?

American Express Company (NYSE:AXP) has long been a Buffett favorite…

Cigna vs Costco Stock: Which Is Best?
Cigna vs Costco Stock: Which Is Best?

Cigna and Costco don’t usually go hand in hand but…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
QMCO alert for Jan 18

Quantum [QMCO] is down 15.61% over the past day.

Buy
51
QRVO alert for Jan 18

Qorvo [QRVO] is up 14.47% over the past day.

Sell
31
ATEX alert for Jan 18

Anterix [ATEX] is up 11.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock